PH31171A - Aminobenzonic acid derivatives useful for treatinggastrointestinal conditions. - Google Patents

Aminobenzonic acid derivatives useful for treatinggastrointestinal conditions.

Info

Publication number
PH31171A
PH31171A PH45633A PH45633A PH31171A PH 31171 A PH31171 A PH 31171A PH 45633 A PH45633 A PH 45633A PH 45633 A PH45633 A PH 45633A PH 31171 A PH31171 A PH 31171A
Authority
PH
Philippines
Prior art keywords
group
treatinggastrointestinal
conditions
acid derivatives
derivatives useful
Prior art date
Application number
PH45633A
Other languages
English (en)
Inventor
Miyazawa Shuhei
Hibi Shigeki
Hoshino Yorihisa
Nagai Mitsuo
Hirota Kazuo
Yamanaka Takashi
Yoshimura Hiroyuki
Mori Takashi
Kikuchi Kouichi
Shibata Hisashi
Yamasu Isao
Mizuno Masanori
Original Assignee
Esai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esai Co Ltd filed Critical Esai Co Ltd
Publication of PH31171A publication Critical patent/PH31171A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C229/60—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in meta- or para- positions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Saccharide Compounds (AREA)
PH45633A 1992-02-04 1993-01-28 Aminobenzonic acid derivatives useful for treatinggastrointestinal conditions. PH31171A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1895992 1992-02-04
JP23553392 1992-09-03

Publications (1)

Publication Number Publication Date
PH31171A true PH31171A (en) 1998-03-20

Family

ID=26355729

Family Applications (1)

Application Number Title Priority Date Filing Date
PH45633A PH31171A (en) 1992-02-04 1993-01-28 Aminobenzonic acid derivatives useful for treatinggastrointestinal conditions.

Country Status (18)

Country Link
US (4) US5389643A (zh)
EP (1) EP0554794B1 (zh)
JP (2) JP2721631B2 (zh)
KR (3) KR970005192B1 (zh)
CN (1) CN1039909C (zh)
AT (1) ATE169015T1 (zh)
AU (2) AU653094B2 (zh)
CA (1) CA2088702C (zh)
DE (1) DE69319939T2 (zh)
DK (1) DK0554794T3 (zh)
ES (1) ES2118842T3 (zh)
FI (1) FI120260B (zh)
HU (1) HU221301B1 (zh)
MX (1) MX9300638A (zh)
NO (1) NO302821B1 (zh)
NZ (2) NZ264220A (zh)
PH (1) PH31171A (zh)
TW (1) TW309521B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH30413A (en) * 1992-03-26 1997-05-09 Boehringer Ingelheim Italia Crystalline forms of endo-2,3-dihydro-n-(8-methyl)-8-azabicyclo-(3,2,1)oct-3-yl)-2-oxo-1h-benzimidazole-1-carboxamides
GB9214184D0 (en) * 1992-07-03 1992-08-12 Smithkline Beecham Plc Pharmaceuticals
JP3235913B2 (ja) * 1993-07-30 2001-12-04 エーザイ株式会社 アミノ安息香酸誘導体
FR2762316B1 (fr) * 1997-04-18 1999-12-17 Sanofi Synthelabo Derives de 5-aryl-3-(8-azabicyclo[3.2.1] octan-3-yl)-1,3,4- oxadiazol-2(3h)-one, leur preparation et leur application en therapeutique
TWI331920B (en) 2001-11-14 2010-10-21 Sucampo Ag Unit dosage form for relieving or treating constipation in human patients
WO2005007600A2 (en) * 2003-07-11 2005-01-27 Eisai Co., Ltd. Novel methods using aminobenzoic acid compounds
US20070155780A1 (en) * 2004-04-15 2007-07-05 Hitoshi Nakata Stabilized composition containing 4-amino-5-chloro-n-[(1r, 3r, 5s)-8-methyl-8-azabicyclo[3.2.1]oct-3-y1]-2-[1-methylbut-2-ynyloxy]benzamide
CN114315585B (zh) * 2022-03-04 2022-05-13 中国医学科学院药用植物研究所 一种羟戊苯甲酸双酯化合物及其制备方法和制药应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL59004A0 (en) * 1978-12-30 1980-03-31 Beecham Group Ltd Substituted benzamides their preparation and pharmaceutical compositions containing them
FR2493848B2 (fr) * 1980-11-07 1986-05-16 Delalande Sa Nouveaux derives des nor-tropane et granatane, leur procede de preparation et leur application en therapeutique
EP0220011A3 (en) * 1985-10-12 1990-01-03 Beecham Group Plc Use of azabicloalkylbenzamides in the treatment of gastrointestinal motility disorders, migraine, emesis, cluster headaches, trigeminal neuralgia and arrhythmia
GB8718345D0 (en) * 1987-08-03 1987-09-09 Fordonal Sa N-substituted benzamides
MX9206075A (es) * 1991-10-24 1993-04-01 Smithkline Beecham Plc Nuevos compuestos antagonistas del receptor 5-hidroxitriptamina y composiciones farmaceuticas que los contienen

Also Published As

Publication number Publication date
NO302821B1 (no) 1998-04-27
FI930462A (fi) 1993-08-05
CA2088702C (en) 2003-08-12
KR970002634B1 (en) 1997-03-07
NO930353D0 (no) 1993-02-02
NZ264220A (en) 1995-03-28
DE69319939T2 (de) 1999-02-18
HU9300283D0 (en) 1993-04-28
TW309521B (zh) 1997-07-01
AU653094B2 (en) 1994-09-15
JPH06128254A (ja) 1994-05-10
ES2118842T3 (es) 1998-10-01
KR930017882A (ko) 1993-09-20
US5578603A (en) 1996-11-26
DE69319939D1 (de) 1998-09-03
FI120260B (fi) 2009-08-31
KR970009570B1 (en) 1997-06-14
EP0554794B1 (en) 1998-07-29
NZ245800A (en) 1995-03-28
CA2088702A1 (en) 1993-08-05
NO930353L (no) 1993-08-05
US5631402A (en) 1997-05-20
US5389643A (en) 1995-02-14
US5599972A (en) 1997-02-04
AU6890894A (en) 1994-09-29
EP0554794A1 (en) 1993-08-11
DK0554794T3 (da) 1999-04-26
FI930462A0 (fi) 1993-02-02
KR970005192B1 (ko) 1997-04-14
JPH107674A (ja) 1998-01-13
MX9300638A (es) 1993-08-01
AU3217693A (en) 1993-08-05
HU221301B1 (en) 2002-09-28
CN1039909C (zh) 1998-09-23
AU668827B2 (en) 1996-05-16
JP2721631B2 (ja) 1998-03-04
HUT69691A (en) 1995-09-28
CN1075145A (zh) 1993-08-11
ATE169015T1 (de) 1998-08-15

Similar Documents

Publication Publication Date Title
AU3821889A (en) 4-oxoquinoline-3-carboxylic acid derivatives, their preparation and their use
PL334915A1 (en) Pyrrolidine derivatives exhibiting phospholipase a2 inhibiting activity
DE69428142T2 (de) Quinolin- oder Quinazolinderivate, deren Herstellung und Verwendung
AU1302388A (en) Method of treating anxiety with tetrahydrobenz(c,d)indole-6- carboxamides
KR970002634B1 (en) Aminobenzoic acid derivatives
HU9503090D0 (en) Novel bisoxadiazolidine derivative
EP0408044A3 (en) Anti-inflammatory and/or anti-allergic composition comprising glutathione derivatives
EP0302967A3 (en) Quinazoline derivative, processes for its production, and cerebral dysfunction remedying agent comprising it as active ingredient
NO852514L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 8-alkyltio-2-piperazino-pyrimido (5,4-d) pyrimidin-derivater.
AU655869B2 (en) An amphoteric tricyclic compound
AU8003594A (en) Quinolinecarboxylic acid derivative and salt thereof